Cryoport director granted stock and options
Cryoport, Inc. director Robert J. Hariri reported equity compensation awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cryoport, Inc. director Robert J. Hariri reported equity compensation awards. He received 10,350 restricted stock rights that vest in full on June 5, 2027 and then convert one-for-one into common shares.
He was also granted options for 16,077 shares of common stock at an exercise price of $15.70 per share, expiring on June 5, 2033, with 1/12 of the options vesting monthly beginning July 5, 2026. Following these awards, he directly holds 61,625 shares of common stock, plus the new option grant.
Insider Trade Summary
Grant/Award: 26,427 shares
Grant/Award
2 txns
Insider
Hariri Robert J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option (Right to Buy Common Stock) | 16,077 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 10,350 | $0.00 | $0.00 |
Holdings After Transaction:
Option (Right to Buy Common Stock) — 16,077 contracts (Direct);
Common Stock — 61,625 shares (Direct)
Footnotes (2)
- F1. Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
- F2. 1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.
Key Figures
Restricted stock rights granted: 10,350 rights
RSU vesting date: June 5, 2027
Options granted: 16,077 options
+4 more
7 metrics
Restricted stock rights granted
10,350 rights
Grant to Robert J. Hariri on June 5, 2026
RSU vesting date
June 5, 2027
Restricted stock rights vest in full on this date
Options granted
16,077 options
Right to buy Cryoport common stock
Option exercise price
$15.70 per share
Exercise price for 16,077 options
Option expiration date
June 5, 2033
Expiry of granted stock options
Shares held after grant
61,625 shares
Total Cryoport common stock directly owned post-transaction
Option vesting schedule
1/12 monthly
Vests on the 5th of each month from July 5, 2026
Key Terms
restricted stock rights, vest, options, exercise price, +1 more
5 terms
restricted stock rights financial
"Reflects grant of restricted stock rights that vest in full on June 5, 2027"
Restricted stock rights are ownership claims in company shares that come with limits on when or how they can be sold or transferred, often tied to time-based or performance conditions. For investors, these rights matter because they affect when insiders truly own or can monetize shares — influencing future share supply, executive incentives, and potential stock price pressure much like a savings account that only becomes withdrawable after meeting set conditions.
vest financial
"vest in full on June 5, 2027, and upon vesting automatically convert"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
options financial
"1/12th of the options vest on the 5th of the month"
Options are contracts that give investors the right to buy or sell an asset at a specific price within a certain time frame. They function like a reservation or a ticket that allows for potential profit or protection against price changes, making them useful tools for managing investment risks or speculating on market movements.
exercise price financial
"conversion_or_exercise_price": "15.7000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Cryoport (CYRX) director Robert J. Hariri receive in this Form 4?
Robert J. Hariri received equity compensation consisting of restricted stock rights and stock options. The filing shows 10,350 restricted stock rights plus 16,077 options to buy Cryoport common stock, all granted on June 5, 2026 as routine director compensation.
When do Robert J. Hariri’s Cryoport restricted stock rights vest?
The restricted stock rights vest in full on June 5, 2027. Upon vesting, the 10,350 restricted stock rights automatically convert into 10,350 shares of Cryoport common stock on a one-for-one basis, increasing his share ownership if still held.
What are the key terms of Robert J. Hariri’s Cryoport stock options?
He was granted options on 16,077 shares at an exercise price of $15.70 per share. One-twelfth of the options vest monthly on the 5th, starting July 5, 2026, and the options expire on June 5, 2033 if not exercised.
Is this Form 4 for a Cryoport insider purchase or a compensation grant?
This Form 4 reflects equity compensation grants, not an open-market purchase. The transactions are coded as awards (code A), covering restricted stock rights and stock options provided to director Robert J. Hariri as part of his compensation arrangement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
